Quotient (NASDAQ:QTNT) released its quarterly earnings data on Monday. The company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.36) by ($0.17), Fidelity Earnings reports. The company had revenue of $6.25 million for the quarter, compared to analysts’ expectations of $5.80 million. Quotient updated its FY 2019 guidance to EPS.
NASDAQ QTNT traded up $0.17 on Wednesday, hitting $6.59. The stock had a trading volume of 1,300 shares, compared to its average volume of 234,933. Quotient has a one year low of $2.78 and a one year high of $9.02. The stock has a market cap of $351.80 million, a price-to-earnings ratio of -3.23 and a beta of 0.45.
Several equities research analysts recently weighed in on the stock. ValuEngine upgraded shares of Quotient from a “hold” rating to a “buy” rating in a research note on Thursday, October 18th. Zacks Investment Research upgraded shares of Quotient from a “sell” rating to a “hold” rating in a research note on Wednesday, October 10th. Finally, BidaskClub upgraded shares of Quotient from a “sell” rating to a “hold” rating in a research note on Tuesday, October 2nd.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Trexquant Investment LP bought a new position in Quotient in the 2nd quarter worth about $102,000. The Manufacturers Life Insurance Company grew its position in Quotient by 341.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 21,820 shares of the company’s stock worth $103,000 after purchasing an additional 16,881 shares during the last quarter. West Chester Capital Advisors Inc. bought a new position in Quotient in the 2nd quarter worth about $120,000. Bank of America Corp DE grew its position in Quotient by 539.0% in the 2nd quarter. Bank of America Corp DE now owns 16,768 shares of the company’s stock worth $135,000 after purchasing an additional 14,144 shares during the last quarter. Finally, Cim Investment Mangement Inc. bought a new position in Quotient in the 2nd quarter worth about $407,000. Hedge funds and other institutional investors own 49.19% of the company’s stock.
WARNING: “Quotient (QTNT) Announces Quarterly Earnings Results, Misses Expectations By $0.17 EPS” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/11/07/quotient-qtnt-announces-quarterly-earnings-results-misses-expectations-by-0-17-eps.html.
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.
See Also: Beta
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.